Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2025 22:00 ET | Source: T1 Energy Inc.

T1 Energy Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes Due 2030 and Common Stock

AUSTIN, Texas and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ( “T1,” “T1 Energy” or the “Company”) today announced the pricing of its previously announced underwritten...
December 11, 2025 21:00 ET | Source: Wealthfront Corporation

Wealthfront Announces Pricing of Initial Public Offering

PALO ALTO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Wealthfront, a tech-driven financial platform helping digital natives turn their savings into wealth, today announced the pricing of its initial...
December 11, 2025 17:07 ET | Source: Twelve Seas Investment Company III

Twelve Seas Investment Company III Announces Pricing of $150,000,000 Initial Public Offering

Los Angeles, California, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company III (NASDAQ: TWLVU) (the “Company”) today announced the pricing of its initial public offering of...
December 11, 2025 17:00 ET | Source: Meshflow Acquisition Corp

Meshflow Acquisition Corp. Announces Closing of $345 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option in Full

CHICAGO, IL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Meshflow Acquisition Corp. (Nasdaq: MESHU) (the “Company”) today announced the closing of its initial public offering of 34,500,000 units, which...
December 11, 2025 16:36 ET | Source: ITHAX Acquisition Corp III

ITHAX Acquisition Corp. III Announces Pricing of $200 Million Initial Public Offering

ITHAX Acquisition Corp III, a SPAC, announced the pricing of its expected listing on Nasdaq, ticker "ITHA", sponsored by Orestes Fintiklis.
December 11, 2025 16:01 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WATERTOWN, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
December 11, 2025 09:43 ET | Source: Enerflex Ltd.

Enerflex Ltd. Announces Redemption of 9.00% Senior Notes Due 2027

CALGARY, Alberta, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announced that it has completed the previously announced redemption of...
December 11, 2025 08:30 ET | Source: C3is Inc.

C3is Inc. Announces Pricing of $9 Million Public Offering

ATHENS, Greece, Dec. 11, 2025 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ: CISS) (the “Company”), a ship-owning company providing dry bulk and tanker seaborne transportation services, today announced the...
December 10, 2025 09:00 ET | Source: Learning Care Group, Inc.

Plainfield, IL Early Childhood Educator Wins National Recognition as Learning Care Group’s Teacher of the Year

Novi, MI, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Learning Care Group, Inc., announced their National Teacher of the Year Award, which honors exemplary early childhood educators and their ability to...
December 10, 2025 07:48 ET | Source: Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

CAMBRIDGE, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (“Fulcrum”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to...